Rapid and Extensive Expansion in the United States of a New Multidrug-resistant Escherichia coli Clonal Group, Sequence Type 1193. (29th June 2018) - Tchesnokova, Veronika L
Abstract: We describe the rapid and ongoing emergence across multiple US cities of a new multidrug-resistant Escherichia coli clone—sequence type (ST) 1193—resistant to fluoroquinolones (100%), trimethoprim-sulfamethoxazole (55%), and tetracycline (53%). ST1193 is associated with younger adults (age <40 years) and currently comprises a quarter of fluoroquinolone-resistant clinical E. coli urine isolates.